Track the 파마리서치바이오 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 파마리서치바이오 has recorded 11 reports. Market capitalisation: €128.4bn. The latest transaction was reported on 4 March 2026 (Sale). Among the most active insiders: 신한캐피탈. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
11 of 11 declarations
파마리서치바이오 opera en el sector de la salud y farmacéutico, cotiza en el mercado XKRX. La empresa se centra en la investigación y el desarrollo de soluciones biofarmacéuticas.